Brain and spinal manifestations of Miller-Dieker syndrome
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published February 18, 2013.
Author Disclosures
- David T. Hsieh, MD,
- Melanie M. Jennesson, MD,
- Elizabeth A. Thiele, MD, PhD,
- Paul A. Caruso, MD,
- Peter T. Masiakos, MS, MD and
- Ann-Christine Duhaime, MD
- David T. Hsieh, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Melanie M. Jennesson, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
received financial assistance from the “association des Amis de l'American Memorial Hospital de Reims” (France).
NONE
NONE
NONE
NONE
NONE
NONE
- Elizabeth A. Thiele, MD, PhD,
1. Board of directors, Tuberous Sclerosis Alliance; 2. Scientific advisory board, Angelman Syndrome Foundation; 3. Scientific advisory board, Charlie Foundation
NONE
1. Novartis Pharmaceuticals, consulting honoraria and travel to meeting; 2. Tuberous Sclerosis Alliance, funding to travel and lodging for board of director meeting
NONE
NONE
Tuberous Sclerosis Complex, Genes, Clinical Features and Therapeutics, Wiley Blackwell 2010
NONE
1. Lundbeck Pharmaceuticals, consultant re: vigabatrin development, 2. Novartis Pharmaceuticals, 3. Upsher Smith Pharmaceuticals, 4. Sunovion Pharmaceuticals
NONE
1. Penry epilepsy courses; faculty, 2. Neuroresident scholar program (sponsored by UCB) , faculty
NONE
participated in Lundbeck Clobazam clinical trials as site PI (not personal financial support, but study funding)
NIH Current, 2004-2011, NIH Program Project Grant P01 NS024279, Molecular Genetics of Inherited Neurological Diseases P.I. Clinical Core (P.I. Xandra O. Breakefield) 2005-2010 Site PI NIH/NCI R01 CA107164, Multicenter trial of rapamycin in angiomyolipoma and lymphangioleiomyomatosis in Tuberous Sclerosis Complex (Dr. S. Dabora, PI)
NONE
2007- Site PI, Tuberous Sclerosis Alliance, TSC Natural History Database Project, 2009-2012Co-PI, Tuberous Sclerosis Alliance, Impact of ketogenic / low-glycemic treatments on TSC pathology
NONE
NONE
NONE
NONE
NONE
NONE
- Paul A. Caruso, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Peter T. Masiakos, MS, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ann-Christine Duhaime, MD
NONE
NONE
NONE
Journal of Neurosurgery Publishing Group, editorial board (Journal of Neurosurgery and Journal of Neurosurgery, Pediatrics)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pediatric Epilepsy Program (DTH, MMJ, EAT) and Departments of Pediatric Neuroradiology (PAC), Pediatric Surgery (PTM), and Pediatric Neurosurgery (A-CD), Massachusetts General Hospital, Boston.
- Correspondence to:
david.hsieh{at}us.af.mil
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.